SynthesisThe international journal of cardiovascular imaging2026
Prognostic value of left atrial function in cardiac amyloidosis: a systematic review and meta‑analysis.
Synthesis in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Atrial Fibrillation in Infiltrative Cardiomyopathies: From Atrial Cardiomyopathy Imaging to Targeted Management-A Narrative Review.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate the prognostic value of left atrial (LA) function parameters, assessed by echocardiography or cardiac magnetic resonance, in patients with cardiac amyloidosis. We conducted a systematic review and meta-analysis of cohort studies evaluating the prognostic role of LA function parameters, such as left atrial reservoir strain (LASr), in confirmed light-chain amyloid cardiomyopathy (AL-CM) or transthyretin amyloid cardiomyopathy (ATTR-CM). Twenty studies were included, comprising a total of 3,260 participants. LASr was inversely associated with all-cause mortality (HR: 0.92; 95% CI: 0.88-0.96), although with low certainty of evidence. LASr was also associated with a lower risk of atrial fibrillation (HR: 0.92; 95% CI: 0.88-0.96), likewise with low certainty. Contractile strain was associated with reduced all-cause mortality (HR: 0.83; 95% CI: 0.76-0.91). The LA stiffness index was associated with increased all-cause mortality (HR: 1.17; 95% CI: 1.09-1.26). Other parameters also showed associations with all-cause mortality; however, the number of available studies was insufficient. In patients with cardiac amyloidosis, assessment of LA function provides incremental prognostic information beyond ventricular parameters for identifying individuals at higher risk of adverse clinical outcomes. Nevertheless, the certainty of the evidence is low or very low, which does not support its routine prognostic use.
Indexed as
Identifiers
41746484What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.